Cynata Therapeutics (ASX: CYP) Share Price

CYP

$0.26–+0.00%

$63.3MRank #953 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$63.3M

Volume

P/E Ratio

-7.57

EPS

-$0.0114

Dividend Yield

0.00%

52-Week High

$0.435

52-Week Low

$0.145

Beta

1.08

Cynata Therapeutics (ASX: CYP) is an Australian-listed company in the Healthcare sector with a market capitalisation of $63.3M and the 953rd-largest security on the ASX by market capitalisation. The CYP share price is $0.26, up 0.00% today and up 44.44% over the past 12 months. Shares have traded between $0.145 and $0.435 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Cynata Therapeutics reported revenue of $0 and a net loss of $2.7M.

Charts

$0.26

24H Range

$0.255

$0.275

52-Week Range

$0.145

$0.435

About Cynata Therapeutics Limited

Headquartered in Cremorne, Australia, Cynata Therapeutics Limited, established in 2003 and formerly known as Eco Quest Limited until its 2013 rebranding, specializes in the development and commercialization of its proprietary Cymerus mesenchymal stem cell technology for human therapeutic applications. Its most advanced therapeutic candidate, CYP-001, has successfully concluded Phase I clinical trials for graft versus host disease. The company's pipeline also includes CYP-004, currently in Phase III trials for osteoarthritis treatment, and CYP-006TK, an innovative polymer-coated silicon wound dressing designed for diabetic wounds. Furthermore, Cynata is advancing therapies for a broad spectrum of conditions such as asthma, heart attacks, coronary artery disease, acute respiratory distress syndrome, brain cancer, sepsis, critical limb ischemia, idiopathic pulmonary fibrosis, and renal transplantation. Cynata maintains a crucial strategic alliance with Fujifilm, which is responsible for the clinical and commercial manufacturing and supply of its Cymerus therapeutic mesenchymal stem cell products.

IPO Date

19 Dec 2007

CEO

Kilian Kelly

Website

cynata.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-2.7M
Total Assets	$4.5M
Total Debt	$0
Free Cash Flow	$-8.8M
Return on Equity	-78.59%
Profit Margin	—
Operating Margin	—

CYP Frequently Asked Questions

What is the Cynata Therapeutics (ASX: CYP) share price?

The CYP share price is $0.26, up 0.00% for the day, based on the latest available ASX market data.

What is Cynata Therapeutics's market capitalisation?

Cynata Therapeutics has a market capitalisation of $63.3M, making it the 953rd-largest security listed on the ASX.

Does Cynata Therapeutics pay a dividend?

CYP does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Cynata Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), CYP reported revenue of $0 and a net loss of $2.7M.

How many CYP shares are on issue?

Cynata Therapeutics has approximately 243,454,000 shares on issue, based on its market capitalisation of $63.3M and current share price.

What sector is Cynata Therapeutics in?

Cynata Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Cynata Therapeutics list on the ASX?

Cynata Therapeutics listed on the Australian Securities Exchange on 19 Dec 2007.

Latest News

Cynata Therapeutics (ASX:CYP) Moves Higher Following Regulatory Progress in Europe

Kalkine3 June 2026

Cynata Therapeutics (ASX:CYP) Moves Higher Following Regulatory Progress in Europe Kalkine

CYP:ASX Announcement - WHO Selects Proposed INN for Cymerus MSCs - 29 May 2026

Market Index29 May 2026

CYP:ASX Announcement - WHO Selects Proposed INN for Cymerus MSCs - 29 May 2026 Market Index

When Can We Expect A Profit From Cynata Therapeutics Limited (ASX:CYP)?

Yahoo Finance9 Oct 2025

When Can We Expect A Profit From Cynata Therapeutics Limited (ASX:CYP)? Yahoo Finance

Insights: Cynata Therapeutics Ltd (ASX:CYP)

smallcaps.com.au30 Oct 2025

Insights: Cynata Therapeutics Ltd (ASX:CYP) smallcaps.com.au

When Will Cynata Therapeutics Limited (ASX:CYP) Turn A Profit?

simplywall.st26 Oct 2025

When Will Cynata Therapeutics Limited (ASX:CYP) Turn A Profit? simplywall.st

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
ADOAnteoTech Limited	$78.2M	$0.024	-10.60	0.00%	▼-7.69%
PTXPrescient Therapeutics Limited	$71.5M	$0.068	-5.28	0.00%	▼-2.86%
ATXAmplia Therapeutics Limited	$56.5M	$0.11	-8.54	0.00%	–+0.00%
CTECryosite Limited	$51.7M	$1.06	10.72	0.00%	–+0.00%
RADRadiopharm Theranostics Limited	$47.3M	$0.02	-0.82	0.00%	▲+5.26%
NOXNoxopharm Limited	$23.7M	$0.077	-3.69	0.00%	▼-3.75%
NSBNeuroScientific Biopharmaceuticals Limited	$21.9M	$0.069	-5.38	0.00%	▲+15.00%
PIQProteomics International Laboratories Limited	$20.6M	$0.125	-4.45	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.265	$0.275	$0.255	$0.26	1M	–+0.00%
11 June 2026	$0.265	$0.275	$0.255	$0.26	1M	▼-3.70%
10 June 2026	$0.27	$0.28	$0.26	$0.27	928K	▲+1.89%
9 June 2026	$0.28	$0.28	$0.26	$0.265	338K	▼-7.02%
8 June 2026	$0.305	$0.305	$0.28	$0.285	59K	▲+1.79%
5 June 2026	$0.305	$0.305	$0.28	$0.28	44K	▼-3.45%
4 June 2026	$0.30	$0.305	$0.29	$0.29	454K	▲+1.75%
3 June 2026	$0.28	$0.295	$0.275	$0.285	513K	▲+3.64%
2 June 2026	$0.28	$0.28	$0.27	$0.275	234K	▼-1.79%
1 June 2026	$0.29	$0.29	$0.27	$0.28	808K	–+0.00%
29 May 2026	$0.265	$0.285	$0.265	$0.28	467K	▲+9.80%
28 May 2026	$0.26	$0.27	$0.255	$0.255	300K	▼-7.27%
27 May 2026	$0.275	$0.275	$0.26	$0.275	269K	▲+5.77%
26 May 2026	$0.285	$0.285	$0.25	$0.26	1.1M	▼-7.14%
25 May 2026	$0.28	$0.28	$0.28	$0.28	115K	–+0.00%
22 May 2026	$0.28	$0.285	$0.28	$0.28	429K	▲+1.08%
21 May 2026	$0.292	$0.295	$0.275	$0.277	572K	▼-4.48%
20 May 2026	$0.295	$0.31	$0.285	$0.29	588K	▼-1.69%
19 May 2026	$0.30	$0.30	$0.29	$0.295	274K	–+0.00%
18 May 2026	$0.305	$0.307	$0.29	$0.295	521K	▼-6.35%
15 May 2026	$0.33	$0.33	$0.315	$0.315	341K	▼-4.55%
14 May 2026	$0.345	$0.35	$0.315	$0.33	446K	▼-5.71%
13 May 2026	$0.34	$0.355	$0.34	$0.35	95K	▲+2.94%
12 May 2026	$0.35	$0.36	$0.335	$0.34	180K	▼-1.45%
11 May 2026	$0.345	$0.355	$0.335	$0.345	615K	▲+1.47%
8 May 2026	$0.315	$0.347	$0.315	$0.34	481K	▲+6.25%
7 May 2026	$0.325	$0.33	$0.31	$0.32	285K	▲+3.23%
6 May 2026	$0.31	$0.325	$0.295	$0.31	429K	▼-3.13%
5 May 2026	$0.34	$0.34	$0.30	$0.32	7.7K	–+0.00%
4 May 2026	$0.305	$0.335	$0.28	$0.32	1.1M	▼-0.62%

About Cynata Therapeutics Limited

IPO Date

19 Dec 2007

CEO

Kilian Kelly

Website

cynata.com

CYP Frequently Asked Questions

What is the Cynata Therapeutics (ASX: CYP) share price?

The CYP share price is $0.26, up 0.00% for the day, based on the latest available ASX market data.

What is Cynata Therapeutics's market capitalisation?

Cynata Therapeutics has a market capitalisation of $63.3M, making it the 953rd-largest security listed on the ASX.

Does Cynata Therapeutics pay a dividend?

CYP does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Cynata Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), CYP reported revenue of $0 and a net loss of $2.7M.

How many CYP shares are on issue?

Cynata Therapeutics has approximately 243,454,000 shares on issue, based on its market capitalisation of $63.3M and current share price.

What sector is Cynata Therapeutics in?

Cynata Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Cynata Therapeutics list on the ASX?

Cynata Therapeutics listed on the Australian Securities Exchange on 19 Dec 2007.

Company

Market Cap

Price

P/E

Div Yield

1D Change

ADOAnteoTech Limited

$78.2M

$0.024

-10.60

0.00%

▼-7.69%

PTXPrescient Therapeutics Limited

$71.5M

$0.068

-5.28

0.00%

▼-2.86%

ATXAmplia Therapeutics Limited

$56.5M

$0.11

-8.54

0.00%

–+0.00%

CTECryosite Limited

$51.7M

$1.06

10.72

0.00%

–+0.00%

RADRadiopharm Theranostics Limited

$47.3M

$0.02

-0.82

0.00%

▲+5.26%

NOXNoxopharm Limited

$23.7M

$0.077

-3.69

0.00%

▼-3.75%

NSBNeuroScientific Biopharmaceuticals Limited

$21.9M

$0.069

-5.38

0.00%

▲+15.00%

PIQProteomics International Laboratories Limited

$20.6M

$0.125

-4.45

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.265	$0.275	$0.255	$0.26	1M	–+0.00%
11 June 2026	$0.265	$0.275	$0.255	$0.26	1M	▼-3.70%
10 June 2026	$0.27	$0.28	$0.26	$0.27	928K	▲+1.89%
9 June 2026	$0.28	$0.28	$0.26	$0.265	338K	▼-7.02%
8 June 2026	$0.305	$0.305	$0.28	$0.285	59K	▲+1.79%
5 June 2026	$0.305	$0.305	$0.28	$0.28	44K	▼-3.45%
4 June 2026	$0.30	$0.305	$0.29	$0.29	454K	▲+1.75%
3 June 2026	$0.28	$0.295	$0.275	$0.285	513K	▲+3.64%
2 June 2026	$0.28	$0.28	$0.27	$0.275	234K	▼-1.79%
1 June 2026	$0.29	$0.29	$0.27	$0.28	808K	–+0.00%
29 May 2026	$0.265	$0.285	$0.265	$0.28	467K	▲+9.80%
28 May 2026	$0.26	$0.27	$0.255	$0.255	300K	▼-7.27%
27 May 2026	$0.275	$0.275	$0.26	$0.275	269K	▲+5.77%
26 May 2026	$0.285	$0.285	$0.25	$0.26	1.1M	▼-7.14%
25 May 2026	$0.28	$0.28	$0.28	$0.28	115K	–+0.00%
22 May 2026	$0.28	$0.285	$0.28	$0.28	429K	▲+1.08%
21 May 2026	$0.292	$0.295	$0.275	$0.277	572K	▼-4.48%
20 May 2026	$0.295	$0.31	$0.285	$0.29	588K	▼-1.69%
19 May 2026	$0.30	$0.30	$0.29	$0.295	274K	–+0.00%
18 May 2026	$0.305	$0.307	$0.29	$0.295	521K	▼-6.35%
15 May 2026	$0.33	$0.33	$0.315	$0.315	341K	▼-4.55%
14 May 2026	$0.345	$0.35	$0.315	$0.33	446K	▼-5.71%
13 May 2026	$0.34	$0.355	$0.34	$0.35	95K	▲+2.94%
12 May 2026	$0.35	$0.36	$0.335	$0.34	180K	▼-1.45%
11 May 2026	$0.345	$0.355	$0.335	$0.345	615K	▲+1.47%
8 May 2026	$0.315	$0.347	$0.315	$0.34	481K	▲+6.25%
7 May 2026	$0.325	$0.33	$0.31	$0.32	285K	▲+3.23%
6 May 2026	$0.31	$0.325	$0.295	$0.31	429K	▼-3.13%
5 May 2026	$0.34	$0.34	$0.30	$0.32	7.7K	–+0.00%
4 May 2026	$0.305	$0.335	$0.28	$0.32	1.1M	▼-0.62%